EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSNGAG00000012557
Gene Symbol: DHCR24
3 Cross references
208 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSNGAG00000000531
Gene Symbol: HMGCR
3 Cross references
270 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSNGAG00000015107
Gene Symbol: PDPK1
3 Cross references
240 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSNGAG00000017600
Gene Symbol: HPD
3 Cross references
204 Possible Orthologues:

40s Ribosomal Protein S10

Ensembl ID : ENSNGAG00000021418
Gene Symbol: LOC103739685
3 Cross references
288 Possible Orthologues:

40s Ribosomal Protein S13-Like

Ensembl ID : ENSNGAG00000020126
Gene Symbol: LOC108491079
2 Cross references
70 Possible Orthologues:

40s Ribosomal Protein S14

Ensembl ID : ENSNGAG00000014327
Gene Symbol: LOC103751139
2 Cross references
116 Possible Orthologues:

40s Ribosomal Protein S14

Ensembl ID : ENSNGAG00000015321
Gene Symbol: LOC103751140
2 Cross references
46 Possible Orthologues:

40s Ribosomal Protein S28

Ensembl ID : ENSNGAG00000010951
Gene Symbol: LOC103751286
2 Cross references
98 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSNGAG00000006974
Gene Symbol: NT5E
3 Cross references
249 Possible Orthologues:

5-Hydroxytryptamine Receptor 1a

Ensembl ID : ENSNGAG00000010968
Gene Symbol: HTR1A
3 Cross references
147 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSNGAG00000017927
Gene Symbol: HTR1B
3 Cross references
245 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).